Mycoplasma Diagnostics Market Huge Growth in Future Scope 2021-2028 | Agilent Technologies, American Type Culture

Mycoplasma, a bacteria which causes infections of the lung, is responsible for the majority of serious pulmonary infections.

SEATTLE, WASHINGTON, UNITED STATES, November 17, 2021 /EINPresswire.com/ — Market Overview:

Mycoplasma, a bacteria which causes infections of the lung, is responsible for the majority of serious pulmonary infections. Children are the most susceptible to infections caused by mycoplasma and the most contagious of all is S. pneumoniae. Mycoplasma may lead to swine respiratory disease, a leading cause of nursery pigs, grower and finisher deaths in the U.S.

Get Sample Report with Latest Covid19 Impact Analysis @ https://www.coherentmarketinsights.com/insight/request-sample/763

Competitive Landscape:

Major players operating in the global mycoplasma diagnostics market include, Agilent Technologies, American Type Culture Collection, PromoCell GmbH, Merck KGaA, Lonza Group, Savyon Diagnostics, Tecan Group, Charles River Laboratories International, F Hoffmann-La Roche and Sartorius Stedim BioOutsource. Thermo Fisher Scientific, and Takara Holding.

Key Market Drivers:

Tuberculosis can have many forms and is usually caused by several strains of a single bacterium, Mycoplasma Tuberculosis. Thus, increasing prevalence of tuberculosis is expected to propel growth of the global mycoplasma diagnostics market over the forecast period. For instance, according to the World Health Organization, in 2018, India reported around 2.69 million cases of tuberculosis.

Moreover, increasing demand for pork is also expected to aid in growth of the market. For instance, according to the U.S. Department of Agriculture, in the U.S., pork’s export share of production is expected to increase from 22.9% in 2019 to 25.8% in 2020 and in 2021, due primarily to strong exports to China.

Get PDF Brochure with Latest Insights @ https://www.coherentmarketinsights.com/insight/request-pdf/763

Covid-19 Impact Analysis

Globally, as of 4:32pm CEST, 15 October 2021, there have been 239,437,517 confirmed cases of COVID-19, including 4,879,235 deaths, reported to WHO. As of 14 October 2021, a total of 6,495,672,032 vaccine doses have been administered. The pork and meat industries have witnessed strong demands with easing of COVID-19 restrictions. In the U.S., there is a strong demand for beef and pork as sales of steaks and burgers from restaurants and hotels recovered following the easing of COVID-19 restrictions. Such scenario is expected to aid in growth of the market.

Key Takeaways

R&D in mycoplasma is expected to propel growth of the global mycoplasma diagnostics market over the forecast period. For instance, in June 2021, the study, “Expression of Serum miR-155 in Children with Mycoplasma pneumoniae Pneumonia and Its Role in Immunity to Mycoplasma pneumonia” reported that miR-155, IL-10, IgG, IgA, CD3+, CD4+, and CD4+/CD8+ were poorly expressed in children with Mycoplasma pneumoniae Pneumonia, and their expression in the acute phase group was significantly lower than that in the recovery phase group.

Major players operating in the global mycoplasma diagnostics market are focused on R&D to expand their product portfolio. For instance, in July 2021, LexaGene Holdings, Inc. reported successful use of its MiQLab System to detect the presence of mycoplasmas. The system detected 100% of the tested mycoplasma samples within two hours, with no false positives.

Purchase This Premium Report To Access Full Information @ https://www.coherentmarketinsights.com/insight/buy-now/763

Table of Content:

1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations

2. Market Overview
o Report Description
• Market Definition and Scope
o Executive Summary
• Market Snippet By Product Type
• Market Snippet By Application
• Market Snippet By Technology
• Market Snippet By End User
• Market Snippet By Region
o Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
• Drivers
• Restraints
• Market Opportunities
o Technological Trends
o PEST Analysis
o Impact Analysis

4. Global Mycoplasma Diagnostics Market, By Product Type, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Reagents & Consumables
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Software’s
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Instruments
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

5. Global Mycoplasma Diagnostics Market, By Application, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Genomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Proteomics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Drug Discovery
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

6. Global Mycoplasma Diagnostics Market, By Technology, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Microarrays
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Microfluidics
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

7. Global Mycoplasma Diagnostics Market, By End User, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, 2021 – 2028
• Segment Trends
o Hospitals
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Diagnostic Labs
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Academic & Research Institutes
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)
o Biotechnology & Pharmaceutical Companies
• Introduction
• Market Size and Forecast, and Y-o-Y Growth, 2021 – 2028, (US$ Million)

8. Global Mycoplasma Diagnostics Market, By Regions, 2021 – 2028 (US$ Million)
o Introduction
• Market Share Analysis, By Region, 2016 and 2028 (%)
• Y-o-Y Growth Analysis, For Regions, 2021 – 2028
o North America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• U.S.
• Canada
o Europe
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Germany
• U.K.
• France
• Italy
• Spain
• Russia
• Rest of Europe
o Asia Pacific
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• China
• India
• Japan
• Australia
• South Korea
• ASEAN
• Rest of APAC
o Latin America
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• Brazil
• Mexico
• Rest of Latin America
o Africa
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• South Africa
• Central Africa
• North Africa
o Middle East
• Market Size and Forecast, By Product Type, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Application, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Technology, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By End User, 2021 – 2028 (US$ Million)
• Market Size and Forecast, By Country, 2021 – 2028 (US$ Million)
• GCC
• Israel
• Rest of Middle East

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Raj Shah
Coherent Market Insights Pvt. Ltd.
+1 206-701-6702
email us here
Visit us on social media:
Facebook
Twitter
LinkedIn
Other


Source: EIN Presswire